Apoptosis-inducing activity of clofazimine in macrophages

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 9, 2011, Pages 4000-4005

  Fukutomi, Yasuo ^a   Maeda, Yumi ^a   Makino, Masahiko ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CLOFAZIMINE; DNA;

APOPTOSIS; ARTICLE; CELL DEATH; CELL NUCLEUS FRAGMENTATION; CELL SIZE; CELLULAR PARAMETERS; COLORIMETRY; CONTROLLED STUDY; DNA ELECTROPHORESIS; ELECTROPHORESIS; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; MACROPHAGE; MORPHOLOGY; NUCLEAR CONDENSATION; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; CELL LINE; CELLS, CULTURED; CLOFAZIMINE; HUMANS; MACROPHAGES; MICE; MICE, INBRED BALB C; MICROSCOPY, FLUORESCENCE; MICROSCOPY, PHASE-CONTRAST; MYCOBACTERIUM LEPRAEMURIUM;

EID: 80051808229     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00434-11     Document Type: Article

References (26)

1. Barry, V C, et al. 1957. A new series of phenazines (rimino-compounds) with high antituberculosis activity. Nature 179:1013-1015.
2. Browne, S G 1965. "B 663" possible anti-inflammatory action in lepromatous leprosy. Lepr. Rev. 36:9-11.
3. Browne, S G, and L M Hogenzeil. 1962. "B 663" in the treatment of leprosy. Supplementary report of the pilot trial. Lepr. Rev. 33:182-184.
4. Chang, Y T 1966. Further studies on B.663 in murine leprosy. Absence of resistance of M. lepraemurium to B.663 and delay in development of resistance to isoniazid. Int. J. Lepr. Other Mycobact. Dis. 34:1-6.
5. Chuaprapaisilp, T, and T. Piamphongsant. 1978. Treatment of pustular psoriasis with clofazimine. Br. J. Dermatol. 99:303-305. (Pubitemid 9008786)
6. Fahy, R J, A I Doseff, and M D Wewers. 1999. Spontaneous human monocyte apoptosis utilizes a caspase-3-dependent pathway that is blocked by endotoxin and is independent of caspase-1. J. Immunol. 163:1755-1762. (Pubitemid 29382172)
7. Franzblau, S G, and J F O'Sullivan. 1988. Structure-activity relationships of selected phenazines against Mycobacterium leprae in vitro. Antimicrob. Agents Chemother. 32:1583-1585.
8. Gockel, H R, et al. 2004. Thalidomide induces apoptosis in human monocytes by using a cytochrome c-dependent pathway. J. Immunol. 172:5103-5109. (Pubitemid 38456439)
9. Goldings, E A 1986. Regulation of B cell tolerance by macrophage-derived mediators: Antagonistic effects of prostaglandin E2 and interleukin 1. J. Immunol. 136:817-822. (Pubitemid 16146360)
10. Krajewska, M M, and R. Anderson. 1993. An in vitro comparison of the effects of the prooxidative riminophenazines clofazimine and B669 on neutrophil phospholipase A2 activity and superoxide generation. J. Infect. Dis. 167:899-904. (Pubitemid 23088260)
11. Lahiri, R., B. Randhawa, and J L Krahenbuhl. 2010. Infection of mouse macrophages with viable Mycobacterium leprae does not induce apoptosis. J. Infect. Dis. 201:1736-1742.
12. Maeda, Y., T. Mukai, J. Spencer, and M. Makino. 2005. Identification of an immunomodulating agent from Mycobacterium leprae. Infect. Immun. 73: 2744-2750. (Pubitemid 40570340)
13. Metzger, Z., J T Hoffeld, and J J Oppenheim. 1980. Macrophage-mediated suppression. I. Evidence for participation of both hydrogen peroxide and prostaglandins in suppression of murine lymphocyte proliferation. J. Immunol. 124:983-988. (Pubitemid 10128639)
14. Nicholson, D W, et al. 1995. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37-43.
15. Niwa, Y., T. Sakane, Y. Miyachi, and M. Ozaki. 1984. Oxygen metabolism in phagocytes of leprotic patients: Enhanced endogenous superoxide dismutase activity and hydroxyl radical generation by clofazimine. J. Clin. Microbiol. 20:837-842. (Pubitemid 15207339)
16. Pope, R M 2002. Apoptosis as a therapeutic tool in rheumatoid arthritis. Nat. Rev. Immunol. 2:527-535. (Pubitemid 37328744)
17. Reddy, V M, J F O'Sullivan, and P R Gangadharam. 1999. Antimycobacterial activities of riminophenazines. J. Antimicrob. Chemother. 43:615-623.
18. Rees, R J 1967. Leprosy. A preliminary review of the experimental evaluation of drugs for the treatment of leprosy. Trans. R. Soc. Trop. Med. Hyg. 61:581-595.
19. Sampaio, E P, E N Sarno, R. Galilly, Z A Cohn, and G. Kaplan. 1991. Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes. J. Exp. Med. 173:699-703.
20. Sandler, E D, V L Ng, and W K Hadley. 1992. Clofazimine crystals in alveolar macrophages from a patient with the AIDS. Arch. Pathol. Lab. Med. 116:541-543.
21. Sarracent, J, and C M Finlay. 1982. The action of clofazimine on the level of lysosomal enzymes of cultured macrophages. Clin. Exp. Immunol. 48:261-267. (Pubitemid 12145519)
22. Shepard, C C, and Y T Chang. 1964. Activity of antituberculosis drugs against Mycobacterium leprae. Int. J. Lepr. 32:260-271.
23. Sukpanichnant, S., et al. 2000. Clofazimine-induced crystal-storing histiocytosis producing chronic abdominal pain in a leprosy patient. Am. J. Surg. Pathol. 24:129-135. (Pubitemid 30033406)
24. Thompson, P A, D F Jelinek, and P E Lipsky. 1984. Regulation of human B cell proliferation by prostaglandin E2. J. Immunol. 133:2446-2453. (Pubitemid 15205828)
25. Wadee, A A, R H Kuschke, and T G Dooms. 1995. The inhibitory effects of Mycobacterium tuberculosis on MHC class II expression by monocytes activated with riminophenazines and phagocyte stimulants. Clin. Exp. Immunol. 100:434-439.
26. Watson, S R, L K Auclair, and F M Collins. 1981. The effect of combined chemotherapy on suppressor T-cell activity in Mycobacterium simiae-infected mice. Immunology 43:459-465. (Pubitemid 11095776)